Intraaortic balloon pump use in high-risk percutaneous coronary intervention

Current Opinion in Cardiology

Volumn 28, Issue 6, 2013, Pages 671-675

  Sharma, Sumeet ^a   Lumley, Matthew ^a   Perera, Divaka ^a  

^a ST THOMAS HOSPITAL   (United Kingdom)

Author keywords

Cardiogenic shock; counterpulsation; high risk percutaneous coronary intervention; intraaortic balloon pump; mechanical support device

Indexed keywords

ACUTE CORONARY SYNDROME; ACUTE HEART INFARCTION; CARDIOGENIC SHOCK; DECISION MAKING; HIGH RISK POPULATION; HUMAN; INTRAAORTIC BALLOON PUMP; MEDICAL DEVICE; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; REVIEW; SHOCK; ST SEGMENT ELEVATION;

HUMANS; INTRA-AORTIC BALLOON PUMPING; MYOCARDIAL INFARCTION; PERCUTANEOUS CORONARY INTERVENTION; RISK; SHOCK, CARDIOGENIC; TREATMENT OUTCOME;

EID: 84886089175     PISSN: 02684705     EISSN: 15317080     Source Type: Journal    
DOI: 10.1097/HCO.0b013e3283652dcc     Document Type: Review

References (17)

1. Kantrowitz A, Tjønneland S, Freed PS, et al. Initial clinical experience with intra-aortic balloon pumpingincardiogenic shock. JAMA 1968;203:113-118.
2. Scheidt S, Wilner G, Mueller H, et al. Intra-aortic balloon counterpulsation in cardiogenic shock: report of a cooperative clinical trial. N Engl J Med 1973; 288:979-984.
3. Kern MJ, Aguirre F, Bach R, et al. Augmentation of coronary blood flow by intra-aortic balloon pumping in patients after coronary angioplasty. Circulation 1993; 87:500-511. (Pubitemid 23040920)
4. Levine GN, Bates ER, Blankenship JC, et al. 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions. J Am Coll Cardiol 2011; 58:e44-e122.
5. Wijns W, Kolh P, Danchin N, et al. Guidelines on myocardial revascularization. Eur Heart J 2010; 31:2501-2555.
6. Kahn JK, Rutherford BD, McConahay DR, et al. Supported 'high risk' coronary angioplasty using intraaortic balloon pump counterpulsation. J Am Coll Cardiol 1990; 15:1151-1155. (Pubitemid 20104578)
7. Perera D, Stables R, Booth J, et al. The balloon pump-assisted coronary intervention study (BCIS-1): rationale and design.AmHeartJ2009; 158:910-916.
8. Romeo F, Acconcia MC, Sergi D, et al. Lack of intra-aortic balloon pump effectiveness in high-risk percutaneous coronary interventions without car-diogenic shock: a comprehensive meta-analysis of randomised trials and observational studies. Int J Cardiol 2013. [Epub ahead of print]
9. Perera D, Stables R, Thomas M, et al. Elective intra-aortic balloon counter-pulsation during high-risk percutaneous coronary intervention: a randomized controlled trial. JAMA 2010; 304:867-874.
10. Perera D, Stables R, Clayton T, et al. Long-term mortality data from the balloon pump-assisted coronary intervention study (BCIS-1): a randomized, controlled trial of elective balloon counterpulsation during high-risk percutaneous coronary intervention. Circulation 2013; 127:207-212.
11. Patel MR, Smalling RW, Thiele H, et al. Intra-aortic balloon counterpulsa-tion and infarct size in patients with acute anterior myocardial infarction without shock: the CRISP AMI randomized trial. JAMA 2011; 306:1329-1337.
12. Kim RJ, Wu E, Rafael A, et al. The use of contrast-enhanced magnetic resonance imaging to identify reversible myocardial dysfunction. N Engl J Med 2000; 343:1445-1453.
13. Sjauw KD, Engström AE, Vis MM, et al. A systematic review and meta-analysis of intra-aortic balloon pump therapy in ST-elevation myocardial infarction: should we change the guidelines? Eur Heart J 2009; 30:459-468.
14. Thiele H, Zeymer U, Neumann FJ, et al. Intraaortic balloon support for myocardial infarction with cardiogenic shock. N Engl J Med 2012; 367:1287-1296.
15. Hochman JS, Sleeper LA, Webb JG, et al. Early revascularization in acute myocardial infarction complicated by cardiogenic shock. SHOCK Investigators. Should we emergently revascularize occluded coronaries for cardio-genic shock? N Engl J Med 1999; 341:625-634.
16. O'Neill WW, Kleiman NS, Moses J, et al. A prospective, randomized clinical trial of hemodynamic support with Impella 2.5 versus intra-aortic balloon pump in patients undergoing high-risk percutaneous coronary intervention. The PROTECT II Study. Circulation 2012; 126:1717-1727.
17. Cheng JM, den Uil CA, Hoeks SE, et al. Percutaneous left ventricular assist devices vs. intra-aortic balloon pump counterpulsation for treatment of car-diogenic shock: a meta-analysis of controlled trials. Eur Heart J 2009; 30:2102-2108.